278 related articles for article (PubMed ID: 11920479)
1. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Kojima H; Shijubo N; Abe S
Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
[TBL] [Abstract][Full Text] [Related]
2. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
Koukourakis MI; Giatromanolaki A; Kakolyris S; O'Byrne KJ; Apostolikas N; Skarlatos J; Gatter KC; Harris AL
Br J Cancer; 1998 May; 77(10):1696-703. PubMed ID: 9635852
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.
Fujioka S; Yoshida K; Yanagisawa S; Kawakami M; Aoki T; Yamazaki Y
Cancer; 2001 Oct; 92(7):1788-97. PubMed ID: 11745251
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
7. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
[TBL] [Abstract][Full Text] [Related]
9. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
[TBL] [Abstract][Full Text] [Related]
11. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
[TBL] [Abstract][Full Text] [Related]
12. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer.
Kikuno N; Yoshino T; Urakami S; Shigeno K; Kishi H; Hata K; Shiina H; Igawa M
Anticancer Res; 2003; 23(2B):1305-12. PubMed ID: 12820387
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Shibusa T; Shijubo N; Abe S
Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466
[TBL] [Abstract][Full Text] [Related]
14. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
[TBL] [Abstract][Full Text] [Related]
15. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.
Imada A; Shijubo N; Kojima H; Abe S
Eur Respir J; 2000 Jun; 15(6):1087-93. PubMed ID: 10885428
[TBL] [Abstract][Full Text] [Related]
16. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.
Li Z; Shimada Y; Uchida S; Maeda M; Kawabe A; Mori A; Itami A; Kano M; Watanabe G; Imamura M
Int J Oncol; 2000 Sep; 17(3):453-60. PubMed ID: 10938383
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of angiogenesis in non-small cell lung cancer.
Giatromanolaki A
Anticancer Res; 2001; 21(6B):4373-82. PubMed ID: 11908693
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Cox G; Thorpe PE; Gatter KC; Harris AL
Clin Cancer Res; 2000 May; 6(5):1917-21. PubMed ID: 10815916
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of angiogenic and of vascular survival factors in non-small cell lung cancer (NSCLC).
Giatromanolaki A
Adv Exp Med Biol; 2000; 476():291-5. PubMed ID: 10949673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
